Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shin Kaitani | M | - |
Japan BCG Laboratory KK
 Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
| Manabu Sugano | M | - |
Japan BCG Laboratory KK
Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
| Shiro Katayama | M | - |
Japan BCG Laboratory KK
Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
| Takahiko Ikegami | M | - |
Japan BCG Laboratory KK
Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
| Jun Saito | M | - |
Japan BCG Laboratory KK
Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
| Hoko Yamashita | M | - |
Japan BCG Laboratory KK
Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
| Tsuguo Sasaki | M | - |
Japan BCG Laboratory KK
Japan BCG Laboratory KK BiotechnologyHealth Technology Japan BCG Laboratory KK engages in vaccine development. It specializes in the research, development, and marketing of Bacillus-Calmette Guérin vaccine. The firm vaccine consists of live bacteria that are used for the treatment of tuberculosis and is the sole supplier in Japan. It offers Freeze-Dried BCG Vaccine for Intradermal Use, Freeze-Dried BCG Vaccine for Percutaneous Use, Freeze-Dried Tuberculin, Purified Protein Derivative(PPD), and Immunobladder® Intravesical. The company was founded in 1952 and is headquartered in Tokyo, Japan. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Japan | 7 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Naoki Nakata
- Personal Network
